Enhanced Expression of IL-18 and IL-18BP in Plasma of Patients with Eczema: Altered Expression of IL-18BP and IL-18 Receptor on Mast Cells
Overview
Pathology
Affiliations
IL-18 has been found to be associated with eczema. However, little is known of the role of IL-18 binding protein (BP) and IL-18 receptor (R) in eczema. We therefore investigated the expression of IL-18, IL-18BP, and IL-18R on mast cells by using flow cytometry analysis and mouse eczema model. The results showed that plasma free IL-18 and free IL-18BP levels in eczema patients were higher than those in healthy controls. IL-18 provoked up to 3.1-fold increase in skin mast cells. IL-18 induced also an increase in IL-18BP+ mast cells, but a reduction of IL-18R+ mast cells in mouse eczema skin. It was found that house dust mite allergen Der p1 and egg allergen OVA induced upregulation of the expression of IL-18, IL-18BP, and IL-18R mRNAs in HMC-1 cells following 2 and 16 h incubation. In conclusion, correlation of IL-18 and IL-18BP in eczema plasma suggests an important balance between IL-18 and IL-18BP in eczema. The decrease in molar concentration ratio of plasma IL-18BP/IL-18 and allergen-induced upregulated expression of IL-18 and IL-18R in skin mast cells of the patients with eczema suggests that anti-IL-18 including IL-18BP therapy may be useful for the treatment of eczema.
Wang F Biomed Rep. 2024; 20(6):87.
PMID: 38665423 PMC: 11040224. DOI: 10.3892/br.2024.1775.
Wang J, Zhan M, Zhai Y, Wang S, Gu F, Zhao Z Clin Exp Immunol. 2024; 217(1):31-44.
PMID: 38587448 PMC: 11188545. DOI: 10.1093/cei/uxae022.
Interleukin-18 and IL-18BP in inflammatory dermatological diseases.
Wang X, Wang L, Wen X, Zhang L, Jiang X, He G Front Immunol. 2023; 14:955369.
PMID: 36742296 PMC: 9889989. DOI: 10.3389/fimmu.2023.955369.
Hawerkamp H, Fahy C, Fallon P, Schwartz C Skin Health Dis. 2022; 2(2):e99.
PMID: 35677926 PMC: 9168024. DOI: 10.1002/ski2.99.
Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation.
McEntee C, Finlay C, Lavelle E Front Immunol. 2019; 10:1266.
PMID: 31231388 PMC: 6568214. DOI: 10.3389/fimmu.2019.01266.